Spots Global Cancer Trial Database for HD17 for Intermediate Stage Hodgkin Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: HD17 for Intermediate Stage Hodgkin Lymphoma
Official Title: HD17 for Intermediate Stages - Treatment Optimization Trial in the First-Line Treatment of Intermediate Stage Hodgkin Lymphoma
Study ID: NCT01356680
Conditions
Study Description
Brief Summary: This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of progression free survival (PFS).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: No
Locations
1st Dept. of Medicine, Cologne University Hospital, Cologne, , Germany
Contact Details
Name: Andreas Engert, Prof.
Affiliation: University of Cologne, German Hodgkin Study Group
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
